Bertrand et al. went further and evaluated parous mothers with GDM compared to nulliparous mothers and observed that those parous mothers with GDM had a 34% and 18% decrease in the risk of in situ breast cancer and invasive ER+ breast cancer, respectively. The gene discussed is ESR1; the disease is gestational diabetes.